Cell Metab 4:107110
Researchers are studying it for obesity and type 2 diabetes because it activates three hormone receptor pathways involved in appetite, glucose regulation, digestion speed, and energy balance
These molecules only interact with the S1 and S2 subsites
While research in humans is still in the early stages, these findings point to the possibility that GLP-1-based treatments could help reduce cravings and withdrawal symptoms in individuals attempting to quit smoking
1R37CA222504-01A1
( 10.1016/j.neubiorev.2007.04.004) [DOI] [PubMed] [Google Scholar] 63.Batista AF, Forny-Germano L, Clarke JR, Lyra e Silva NM, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JFet al